Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nienke J.E. Haverkate"'
Autor:
Sabine Haggenburg, Tom Reuvekamp, Quincy Hofsink, Cilia R. Pothast, Romy C. Dijkland, Kayleigh van Dijk, Annoek E.C. Broers, Jaap van Doesum, Rob S. van Binnendijk, Gerco den Hartog, Michel S. Bhoekhan, Nienke J.E. Haverkate, Sandra Vogels-Nooijen, Inger S. Nijhof, Mirjam H.M. Heemskerk, Caroline E. Rutten, Abraham Goorhuis, Mette D. Hazenberg
Publikováno v:
HemaSphere, Vol 7, p e2387009 (2023)
Externí odkaz:
https://doaj.org/article/f27de6ba7a7a4e10bede6e7c2ec64a82
Autor:
Quincy Hofsink, Sabine Haggenburg, Birgit I. Lissenberg-Witte, Annoek E.C. Broers, Jaap A. van Doesum, Rob S. van Binnendijk, Gerco den Hartog, Michel S. Bhoekhan, Nienke J.E. Haverkate, Johan van Meerloo, Judith A. Burger, Joey H. Bouhuijs, Gaby P. Smits, Dorine Wouters, Ester M.M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sandra Vogels-Nooijen, Nynke Rots, Josine van Beek, Mirjam H.M. Heemskerk, Kazimierz Groen, Tom van Meerten, Pim G.N.J. Mutsaers, Marit J. van Gils, Abraham Goorhuis, Caroline E. Rutten, Mette D. Hazenberg, Inger S. Nijhof, Iris M.J. Kant, Thecla Graas, Belle Toussaint, Sterre de Jong, Shahan Darwesh, Sandjiv S. Mahes, Dora Kamminga, Matthijs Koelewijn, Gino Faber, Guus Beaumont, Marije D. Engel, R. Cheyenne N. Pierie, Suzanne R. Janssen, Edith van Dijkman, Jarom Heijmans, Yara Y. Witte, Rogers A. Nahui Palomino, Said Z. Omar, Sonja Zweegman, Arnon P. Kater, Caya van den Vegt, Ilonka Arends-Halbesma, Emma de Pater, Margriet J. Dijkstra, Nynke Y. Rots, Esther Siteur-van Rijnstra, Dennis M. de Rooij, Rogier W. Sanders, Meliawati Poniman, Wouter Olijhoek, Jacqueline van Rijswijk, Tim Beaumont, Lusia Çetinel, Louis Schellekens, Yvonne M. den Hartogh, Jacqueline Cloos, Suzanne S. Weijers, Saïda Tonouh-Aajoud, Selime Avci, Elianne Roelandse-Koop, Willem A. Dik
Publikováno v:
EClinicalMedicine, Vol 61, Iss , Pp 102040- (2023)
Summary: Background: Patients with haematological malignancies have impaired antibody responses to SARS-CoV-2 vaccination. We aimed to investigate whether a fourth mRNA COVID-19 vaccination improved antibody quantity and quality. Methods: In this coh
Externí odkaz:
https://doaj.org/article/b6705aeb989e44eeb7ee10f048616947
Autor:
Cilia R. Pothast, Quincy Hofsink, Sabine Haggenburg, Bhoekhan S. Michel, Nienke J.E. Haverkate, Romy C. Dijkland, Kayleigh Van Dijk, Frederik J.H. Falkenburg, Annoek E.C. Broers, Jaap van Doesum, Robert S. Van Binnendijk, Gerco Den Hartog, Judith A. Burger, Joey H. Bouhuijs, Birgit I. Lissenberg-Witte, Gaby P. Smits, Dorine Wouters, Ester M.M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sonja Zweegman, Arnon P. Kater, Kaz Groen, Tom van Meerten, Pim G.N.J. Mutsaers, Tim Beaumont, Marit J. Van Gils, Abraham Goorhuis, Mette D. Hazenberg, Inger S. Nijhof, Mirjam H.M. Heemskerk, Caroline E. Rutten
Publikováno v:
Blood. 140:8347-8349
Autor:
Cilia R. Pothast, Quincy Hofsink, Sabine Haggenburg, Michel Bhoekhan, Nienke J.E. Haverkate, Romy C. Dijkland, Kayleigh van Dijk, Frederik J.H. Falkenburg, Annoek E.C. Broers, Jaap van Doesum, Robert S. van Binnendijk, Gerco den Hartog, Judith A. Burger, Joey H. Bouhuijs, Birgit I. Lissenberg-Witte, Gaby P. Smits, Dorine Wouters, Ester M.M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sonja Zweegman, Arnon P. Kater, Kaz Groen, Tom van Meerten, Pim G.N.J. Mutsaers, Tim Beaumont, Marit J. van Gils, Abraham Goorhuis, Mette D. Hazenberg, Inger S. Nijhof, Mirjam H.M. Heemskerk, Caroline E. Rutten
Publikováno v:
Blood. 140:1957-1959
Autor:
Quincy Hofsink, Sabine Haggenburg, Birgit I. Lissenberg-Witte, Annoek E.C. Broers, Jaap A. van Doesum, Robert Samuel van Binnendijk, Gerco den Hartog, Michel S. Bhoekhan, Nienke J.E. Haverkate, Johan van Meerloo, Judith A. Burger, Joey H. Bouhuijs, Gaby Smits, D. Wouters, Ester M.M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sandra Vogels-Nooijen, Nynke Rots, Josine van Beek, Mirjam HM Heemskerk, Kazimierz Groen, Tom van Meerten, Pim G. N. J. Mutsaers, Marit J. van Gils, Abraham Goorhuis, Caroline E. Rutten, Mette D. Hazenberg, Inger S. Nijhof, COBRA KAI Study Team
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af25b3e045ca98dda77f70be99ea7703
https://doi.org/10.2139/ssrn.4375614
https://doi.org/10.2139/ssrn.4375614
Autor:
Yannouck F. van Lier, Thierry Rolling, Gabriel K. Armijo, Bing Zhai, Nienke J.E. Haverkate, Ellen Meijer, Erfan Nur, Bianca Blom, Jonathan U. Peled, Marcel R.M. van den Brink, Tobias M. Hohl, Mette D. Hazenberg, Kate A. Markey
Publikováno v:
van Lier, Y F, Rolling, T, Armijo, G K, Zhai, B, Haverkate, N J E, Meijer, E, Nur, E, Blom, B, Peled, J U, van den Brink, M R M, Hohl, T M, Hazenberg, M D & Markey, K A 2023, ' Profiling the Fungal Microbiome after Fecal Microbiota Transplantation for Graft-versus-Host Disease : Insights from a Phase 1 Interventional Study ', Transplantation and Cellular Therapy, vol. 29, no. 1, pp. 63.e1-63.e5 . https://doi.org/10.1016/j.jtct.2022.10.011
Transplantation and Cellular Therapy, 29(1), 63.e1-63.e5. Elsevier BV
Transplantation and Cellular Therapy, 29(1), 63.e1-63.e5. Elsevier BV
Disruption of the intestinal bacterial microbiota is frequently observed in the context of allogeneic hematopoietic cell transplantation (HCT) and is particularly pronounced in patients who develop graft-versus-host disease (GVHD). Donor fecal microb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::982001385a663afbf4f96ad5d07bbe62
https://research.vumc.nl/en/publications/de7854bd-d2b7-4ebe-8796-93b9f2ade8e3
https://research.vumc.nl/en/publications/de7854bd-d2b7-4ebe-8796-93b9f2ade8e3
Autor:
Sabine Haggenburg, Quincy Hofsink, Birgit I. Lissenberg-Witte, Annoek E.C. Broers, Jaap A. van Doesum, Rob S. van Binnendijk, Gerco den Hartog, Michel S. Bhoekhan, Nienke J.E. Haverkate, Judith A. Burger, Joey H. Bouhuijs, Gaby P. Smits, Dorine Wouters, Ester M.M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sonja Zweegman, Arnon P. Kater, Mirjam H.M. Heemskerk, Kaz Groen, Tom van Meerten, Pim G.N.J. Mutsaers, Tim Beaumont, Marit J. van Gils, Abraham Goorhuis, Caroline E. Rutten, Mette D. Hazenberg, Inger S. Nijhof
ImportanceIn patients with hematologic malignancies, the immunogenicity of the standard 2-dose mRNA-1273 coronavirus disease 19 (COVID-19) vaccination schedule is often insufficient due to underlying disease and current or recent therapy.ObjectiveTo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7042aeaafc39feae669e966d1603be0b
https://doi.org/10.1101/2022.04.08.22273602
https://doi.org/10.1101/2022.04.08.22273602